Your browser doesn't support javascript.
loading
Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis.
Madonna, Rosalinda; Barachini, Serena; Ghelardoni, Sandra; Lu, Lin; Shen, Wei-Feng; De Caterina, Raffaele.
Affiliation
  • Madonna R; Department of Surgical, Medical, and Molecular Pathology and Critical Care, University of Pisa and Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy.
  • Barachini S; Department of Clinical and Experimental Medicine, Laboratory for Cell Therapy, University of Pisa, Pisa, Italy.
  • Ghelardoni S; Department of Pathology, Laboratory of Biochemistry, University of Pisa, Pisa, Italy.
  • Lu L; Department of Cardiovascular Medicine, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, 197 Rui Jin Road II, Shanghai 200025, People's Republic of China.
  • Shen WF; Department of Cardiovascular Medicine, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, 197 Rui Jin Road II, Shanghai 200025, People's Republic of China.
  • De Caterina R; Department of Surgical, Medical, and Molecular Pathology and Critical Care, University of Pisa and Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy.
Cardiovasc Res ; 120(2): 132-139, 2024 03 13.
Article in En | MEDLINE | ID: mdl-38242632
ABSTRACT
The chromogranin-secretogranin secretory proteins-granins-are acidic proteins localized in granules of endocrine cells and neurons. The chromogranin family includes chromogranins A (CgA) and B, as well as secretogranin II (once called chromogranin C). Members of this family undergo catalytic proteolysis to produce active peptides. The CgA-derived peptides vasostatin-1 and vasostatin-2, in particular, appear to protect against atherosclerosis, suppressing the expression of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, as well as exerting vasodilatory effects by enhancing nitric oxide bioavailability. Vasostatin-1 also suppresses vasoconstriction and abnormal angiogenesis. Vasostatin-1 and vasostatin-2 may be novel therapeutic targets for atherosclerosis and coronary heart disease, also protecting the myocardium against ischaemic damage.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Chromogranins / Calreticulin / Atherosclerosis Limits: Humans Language: En Journal: Cardiovasc Res Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Chromogranins / Calreticulin / Atherosclerosis Limits: Humans Language: En Journal: Cardiovasc Res Year: 2024 Document type: Article